27N0 logo

Cannovum Cannabis
27N0

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€882.86K
EV
-
Shares Outstanding
2.31M
Beta
2.36
Industry
-

Wall Street View

Analyst Rating
-
Analyst Target Price
-
Number of Analysts
0
P/E 2022E
-
P/Revenue 2022E
-

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2022E
-
Net Profit Margin 2022E
-
ROE 2022E
-
ROCE 2021
-0.97%

Dividends

DPS 2022E
-
Payout Ratio 2022E
-
Div. Yield 2022E
-
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Cannovum Cannabis AG

gainify
27N0 logo

Cannovum Cannabis AG

27N0

Cannovum Cannabis AG engages in the manufacturing, wholesaling, and importing of medical cannabis products in Berlin. It also focuses on the import of medical cannabis and medical-scientific education, as well as distribution for facilitated access to cannabis-based t...

Sector

Industry

CEO

Marten, Pia

Employees

IPO Date

Headquarters

Rheinsberger Street 76/77, Berlin, Berlin, 10115, Germany

📊 Stock Price & Performance

Review the recent 27N0 stock performance trends:Past 3 Months: The stock has -29.25%. Last updated: December 31, 2025 at 11:43 PM Eastern Time

Cannovum Cannabis (27N0) is considered a high volatility stock. It has a beta of 2.36, which means it typically moves 2.36 times as much as the broader market. Last updated: December 31, 2025 at 11:43 PM Eastern Time

💰 Financial Metrics & Reports

The current Cannovum Cannabis (27N0) market capitalization is approximately €882.86K, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Cannovum Cannabis's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:43 PM Eastern Time

In the most recently reported fiscal year, Cannovum Cannabis (27N0) generated net income of €-0.11M, compared with €-30.57K in the prior fiscal year, representing a -253.26% year over year change. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions.

📅 Earnings & Dividends

Cannovum Cannabis (27N0) does not currently pay a dividend. Over the last twelve months (LTM), the company paid €0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future.

📈 Analyst Information

Based on the latest available analyst coverage, Cannovum Cannabis (27N0) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice.

Like other publicly traded stocks, Cannovum Cannabis (27N0) shares are bought and sold on stock exchanges such as DB and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Cannovum Cannabis (27N0) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

ℹ️ Company Information

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add 27N0 to your watchlist.

Cannovum Cannabis trades under the ticker symbol 27N0 on the DB stock exchange. The ticker 27N0 is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

Cannovum Cannabis (27N0) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Cannovum Cannabis (27N0) stock peers based on overlapping products, services, and competitive dynamics:N4 Pharma (N4P)Pulmatrix (PULM)Aspire Biopharma Holdings (ASBP)Voyageur Pharmaceuticals (VM)Financière de Tubize (TUB) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Cannovum Cannabis.

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2026 Gainify. All rights reserved.